Glaxosmithkline | GSK - Чистый доход





Чистый доход Изменить Дата
AbbVie USD 695M 1.12B 2026-03
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Bausch Health Companies USD -1.42B 1.31B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Drreddys Laboratories INR 2.21B 9.89B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 1.74B 890.94M 2026-03
J&J USD 5.24B 119M 2026-03
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.16B 747M 2026-03
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Takeda JPY -24.32B 127.96B 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Zoetis USD 601M 2M 2026-03